_________
false
אבוגן בע"מ
2
380
EVOGENE LTD
Corporation no:
512838723
10571
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
28/05/2019
www.isa.gov.il
www.tase.co.il
Reference:
2019-02-051880
Time of broadcast:
13:36
13:12:26
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
Please note that in the case of delayed publication of report, no changes will be allowed after the form is submitted.
Delay the publication of a report
28/05/2019
14:00
1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.
2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Press release: Evogene Reports First Quarter of 2019 Financial Results
1Q2019_financial_results_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
-1
Date of revision of form structure:
30/04/2019
Address:
Gad Feinstein St
13, P.O.B 2100
,
Rehovot
76121
,
Tel:
08-9311900
,
Fax:
08-9466724
E-mail address:
ofer.haviv@evogene.com
Company site:
www.evogene.com
Previous names of reporting entity:
Name of the Signatory:
Masliah Sassi
Position of Signatory in the reporting corporation:
Director of Legal Affairs & Company Secretary
Name of Employer Company:
Address:
Gad Feinstein
13
,
Rehovot
7612001
Telephone:
08-9311901
Facsimile:
08-9466724
E-mail:
sassi.masliah@evogene.com
1